PharmaShots | Incisive News in 3 Shots

Subscribe Now

Antibody Treatment

PharmaShots Interview: Xencor's Bassil I. Dahiyat Shares Insight on the US FDA's Approval of COVID-19 Antibody Treatment Leveraging its Technology

PharmaShots Interview: Xencor's Bassil I. Dahiyat Shares Insight on the US FDA's Approval of COVID-19 Antibody Treatment Leveragin...

August 3, 2021

Eli Lilly Seeks the US FDA's EUA for its COVID-19 Antibody Treatment

Eli Lilly Seeks the US FDA's EUA for its COVID-19 Antibody Treatment

October 8, 2020

Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea

Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea

July 20, 2020

Eli Lilly to Initiate P-I Study of its Second Antibody Treatment Against COVID-19

Eli Lilly to Initiate P-I Study of its Second Antibody Treatment Against COVID-19

June 8, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us